SIC
HCAT icon

SJS Investment Consulting’s Health Catalyst HCAT Stock Holding History

SJS Investment Consulting’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78 Buy
39
+30
+333% +$43 ﹤0.01% 2655
2026
Q1 		$12 Buy
+9
New +$17 ﹤0.01% 2414
2022
Q4 		– Sell
-24
Closed – – 1646
2022
Q3 		$0 Buy
+24
New +$318 ﹤0.01% 1235

Other funds holding HCAT

NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
7WCP
71 West Capital Partners Boston, Massachusetts $2.89B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
SC
Sepio Capital Salt Lake City, Utah $1.99B AUM 22.34% 1-Year Est. Return

SJS Investment Consulting's HCAT Position: Q2 2026 in Review

SJS Investment Consulting increased its Health Catalyst (HCAT) stake by 333% in Q2 2026, buying an estimated $43 and bringing the position to 39 shares worth $78. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

SJS Investment Consulting first reported a position in HCAT in Q3 2022 and has held it in 3 quarters since. 49 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • SJS Investment Consulting held 39 shares of Health Catalyst worth $78 as of Q2 2026.
  • SJS Investment Consulting bought 30 Health Catalyst shares in Q2 2026, an estimated $43.
  • Health Catalyst made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2655 holding.
  • SJS Investment Consulting first reported a position in Health Catalyst in Q3 2022 and has held it in 3 quarters since.
  • 49 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.